Heres a closer look at the four major GLP-1 drugs on the market (Ozempic, Mounjaro, Wegovy, and Zepbound): Of these medications, only Zepbound (known generically as tirzepatide) is FDA-approved to treat sleep apnea in those with a body mass index (BMI) of 30 or higher
This slow release helps people feel full longer and reduces appetite, which can lead to weight loss
However, this same mechanism is responsible for nausea, bloating, vomiting, and early satiety, especially when the body has not yet adapted to the drug
CHAKRABARTI: Yeah
Clear and colorless is the standard
Distribution Semaglutide absolute volume of distribution is approximately 8 L in patients with type 2 diabetes